Cargando…
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
BACKGROUND: Trimethylation of lysine 27 on histone H3 (H3K27me3) by enhancer of zeste homolog 2 (EZH2) is an epigenetic mark that mediates gene silencing. EZH2 is overexpressed and correlates with poor prognosis in many cancers. However, the clinical implication of H3K27me3 in human malignancies has...
Autores principales: | He, Li-Ru, Liu, Meng-Zhong, Li, Bin-Kui, Rao, Hui-Lan, Liao, Yi-Ji, Guan, Xin-Yuan, Zeng, Yi-Xin, Xie, Dan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804715/ https://www.ncbi.nlm.nih.gov/pubmed/20028503 http://dx.doi.org/10.1186/1471-2407-9-461 |
Ejemplares similares
-
Preoperative chemoradiotherapy for locoregional esophageal cancer: preliminary report.
por: Kim, S. B., et al.
Publicado: (1995) -
Genomic imprinting of Xist by maternal H3K27me3
por: Inoue, Azusa, et al.
Publicado: (2017) -
H3K27me3-H3K4me1 transition at bivalent promoters instructs lineage specification in development
por: Yu, Yue, et al.
Publicado: (2023) -
Coordination of zygotic genome activation entry and exit by H3K4me3 and H3K27me3 in porcine early embryos
por: Bu, Guowei, et al.
Publicado: (2022) -
Maternal H3K27me3 controls DNA methylation-independent genomic imprinting
por: Inoue, Azusa, et al.
Publicado: (2017)